CHMP backs new therapy for 1L AML, triple combos for asthma

EMA’s CHMP this month recommended four new medicines for approval, including a new front-line therapy for AML and triple combination therapies for asthma.

The agency recommended approval for

Read the full 282 word article

How to gain access

Continue reading with a
two-week free trial.